The drug’s Phase 3 results are comparable to those of Trodelvy, a TROP2-targeting ADC marketed by Gilead Sciences as a second-line treatment for HR positive, HER2 negative breast cancer ...

北京时间1月17日，荣昌生物联合创始人、首席执行官（CEO）房健民博士在第43届摩根大通医疗健康年会（JPM）发表演讲。荣昌生物在报告中表示 ...

The Warren and Katharine Schlinger Laboratory for Chemistry and Chemical Engineering, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125, ...

Image credit: Shutterstock / Piotr Swat. Chugai Pharmaceutical and Araris Biotech have entered an antibody-drug conjugate (ADC)-focused research collaboration and option-to-license agreement worth up ...

Visibly alarmed by the situation, Akufo-Addo paused his address briefly to ensure his ADC received urgent care before resuming his speech. The aide-de-camp of the Vice President, Mahamudu Bawumia ...

Faculty of Chemistry and Earth Sciences, Institute for Organic Chemistry and Macromolecular Chemistry, Friedrich Schiller University Jena, 07743 Jena, Germany Department of Paleobiotechnology, Leibniz ...

Therefore, N,N′-carbonyldiimidazole was used in the current study to react with carboxylic acid to obtain a highly active acyl imidazole. An amine was added directly, and the mixture was reacted for ...

Val-Cit-PAB-MMAE 是一种用于靶向药物递送和抗体-药物偶联物（ADC）研究的多功能化学分子。它包含了一个酶敏感的连接子和强效的细胞*性药物。

Background Middle meningeal artery embolization (MMAE) is a safe and effective treatment for chronic subdural hematoma (cSDH); however, the appropriate level of postoperative care is unknown.

【财华社讯】创胜集团-B(06628.HK)公布，2024年圣安东尼奥乳腺癌研讨会(SABCS)发表了基于人源化LIV-1抗体的新型抗体偶联药物(ADC)的最新临床前研究结果。